Mayara Paschalidis

Mayara Paschalidis

Auto-generated profile, based on publicly available information

Mayara Paschalidis

Sleep Institute, Associação Fundo de Incentivo à Pesquisa, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Epidemiologia e Serviços de Saúde
Verified
Journal Article
Open access
PDF file
MPMayara Paschalidis
Mayara Paschalidis
TKThais Cláudia Roma de Oliveira Konstantyner
Thais Cláudia Roma de Oliveira Konstantyner
SSSharon Sanz Simon
Sharon Sanz Simon
CMCamila Bertini Martins
Camila Bertini Martins
Objective: to analyze trends in mortality rates due to Alzheimer’s disease in Brazil and its macro-regions by age and sex, from 2000 to 2019. Methods: this was a time-series study on mortality from Alzheimer’s disease in Brazil and its macro-regions by age and sex; data were obtained from the Mortality Information System; a Prais-Winsten model was used to analyze trends. Results: there were 211,658 deaths in the period analyzed, with an increasing trend in Alzheimer’s disease mortality in Brazil in elderly people aged 60-69 years (APC = 4.3; 95%CI 2.9;5.9), 70-79 years (APC = 8.1; 95%CI 4.8;11.5) and ≥ 80 years (APC = 11.3; 95%CI 8.1;14.6) and in all macro-regions, age groups and sexes. Conclusion: Brazil and all its macro-regions showed a rising trend in Alzheimer’s disease mortality rates, following the global trend.

13 February 2024 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
BMBruna Pereira Marquezini
Bruna Pereira Marquezini
MMMariana Moysés-Oliveira
Mariana Moysés-Oliveira
AKAnna Kloster
Anna Kloster
LCLais Cunha
Lais Cunha
TDTais Bassani Deconto
Tais Bassani Deconto
STSergio Tufik
Sergio Tufik
Pogo transposable element-derived protein with ZNF domain (POGZ) gene encodes a chromatin regulator and rare variants on this gene have been associated with a broad spectrum of neurodevelopmental disorders, such as White-Sutton syndrome. Patient clinical manifestations frequently include developmental delay, autism spectrum disorder and obesity. Sleep disturbances are also commonly observed in these patients, yet the biological pathways which link sleep traits to the POGZ-associated syndrome remain unclear. We screened for sleep implications among individuals with causative POGZ variants previously described. Sleep disturbances were observed in 52% of patients, and being obese was not observed as a risk factor for sleep problems. Next, we identified genes associated with sleep-associated traits among the POGZ regulatory targets, aiming to uncover the molecular pathways that, when disrupted by POGZ loss of function, contribute to the aetiology of sleep phenotypes in these patients. The intersect between POGZ targets and sleep-related genes was used in a pathway enrichment analysis. Relevant pathways among these overlapping genes are involved in the regulation of circadian rhythm, tau protein binding, ATPase activator activity. This study may represent the beginning for novel functional investigations on shared molecular mechanisms between sleep disturbances and rare developmental syndromes related to POGZ and its regulatory targets.